SUMMARY In order to measure the effect of a decrease in afterload on systolic time intervals, left ventricular end-systolic diameter, and left ventricular wall stress, eight healthy young persons underwent a randomised placebo controlled trial of terbutaline before and during atenolol treatment. Pre-ejection period index, left ventricular end-systolic diameter, and wall stress all decreased after terbutaline, the decrease being clearly dose dependent. This was identical before and during atenolol administration. Consequently the observed changes were induced by beta-2 elicited vasodilatation, possibly combined with some decrease of parasympathetic tone. A close correlation between changes in pre-ejection period index (PEPI) and changes in left ventricular end-systolic diameter (LVESD) and wall stress was shown both before and during atenolol treatment. When using non-invasive methods in the evaluation of changes in contractility, it is important to correct for changes in preload and afterload. For end-systolic diameter. Left ventricular end-systolic diameter, on the other hand, is relatively unchanged by changes in preload.45 Pre-ejection period index and pre-ejection period/left ventricular ejection time (PEP/LVET) are the systolic time intervals which are best correlated to changes in contractility.67 These variables, however, tend to decrease both with a reduction in afterload8 and with an increase in contractility,6 besides the above mentioned preload induced changes.2 Terbutaline is a relatively specific beta-2 stimulator9 and will thus mainly tend to decrease afterload. At the same time a reflex increase in heart rate will take place.
changes in left ventricular end-4ystolic diameter or wall stress.
Systolic time intervals are very sensitive to changes in preload, afterload, pulse rate, and contractility. It is relatively simple to correct for changes in pulse rate. I In order to be able to use systolic time intervals more confidently during pharmacological interventions it is essential to be able to estimate the degree of change which might be caused by changes in preload and afterload, before ascribing the results to changes in contractility. In a previous study we used simultaneously recorded systolic time intervals and echocardiographic variables in the evaluation of the circulatory effect of preload reduction, and found it possible to estimate the degree of change in pre-ejection period index, which was to be expected after changes in preload. 2 Changes in afterload will mainly tend to after left ventricular end-systolic volume, while left ventricular end-diastolic volume will only be changed to a minor degree. 3 Echocardiographically this should be recorded as changes mainly in the left ventricular Supported by the Danish Heart Foundation.
Accepted for publication 3 May 1983 end-systolic diameter. Left ventricular end-systolic diameter, on the other hand, is relatively unchanged by changes in preload.45 Pre-ejection period index and pre-ejection period/left ventricular ejection time (PEP/LVET) are the systolic time intervals which are best correlated to changes in contractility.67 These variables, however, tend to decrease both with a reduction in afterload8 and with an increase in contractility,6 besides the above mentioned preload induced changes.2 Terbutaline is a relatively specific beta-2 stimulator9 and will thus mainly tend to decrease afterload. At the same time a reflex increase in heart rate will take place.
The purpose of the present study was to measure changes in left ventricular end-systolic diameter and left ventricular systolic wall stress caused by afterload reduction by terbutaline, when given alone and after pretreatment with atenolol in an attempt to block the increase in heart rate, and to correlate these changes to changes in pre-ejection period and PEP/LVET.
When the effect of heart rate, preload, and afterload can be accounted for, it is assumed that residual changes in pre-ejection period index and PEP/LVET are caused by changes in contractility.
Non-invasive measuring of the circulatory effect of afterload reduction Table 1 Heart rate, systolc and diastolic bloodpresswee, pusepressure, and mean blood pressure before (cntrol) and after injections ofterbutaline and saline, and during treatment uith atenolol (mean ± SD) taken. An intravenous dose of 0 5 ,tg terbutaline/kg body weight was given and new measurements were taken after 10 minutes. Further intravenous doses of terbutaline 1 ,ug/kg, 2 jig/kg, and 4 ,ug/kg were administered, with 10 minute intervals, and after each dose repeat measurements were performed. (2) As (1) but with injection of normal saline instead of terbutaline. (3) As (1) but without pretreatment with atenolol. (4) As (2) 
Results
The results are shown in Tables 1 to 3 . None of the variables was significantly changed after saline injection. Terbutaline increased the heart rate both when given alone and after pretreatment with atenolol. Systolic blood pressure increased and diastolic blood pressure decreased leading to an increase in pulse pressure while the mean blood pressure was virtually unchanged. This response was similar after atenolol pretreatment (Tables 1 to 3) .
Pre-ejection period index and PEP/LVET decreased as expected when terbutaline was given alone and slightly less when given together with atenolol (Table 2) .
Left ventricular end-diastolic dimension was unchanged while left ventricular end-systolic dimension and systolic wall stress decreased significantly after terbutaline. Atenolol alone decreased the wall stress partly because of a lower systolic pressure, and the response to terbutaline was attenuated by atenolol pretreatment (Table 3) .
There was a very close linear correlation between A PEPI % or A PEP/LVETl/o and ALVESD% or A S% which was identical when terbutaline was given alone or with atenolol. Even the correlation between A QSII5I% and A LVESDD% or A S% was statistically (a) significant (Table 4) . Graphically the relation between pre-ejection period index and left ventricular endsystolic dimension is seen in Fig. 1 . The relation between A LVESD as a percentage of the mean value and A PEPI as a percentage of the mean value is depicted in Fig. 2 . The difference in the slope of the linear correlation when terbutaline was given and after atenolol pretreatment was not significant.
Discussion
Terbutaline is a relatively specific beta-2 stimulator.9 A single group of authors has suggested from indirect evidence that salbutamol, which resembles terbutaline, also possesses a positive inotropic effect (beta-I stimulation),'2 but according to most authors the beta-I stimulation is negligible in the concentrations used in this study in comparison to the beta-2 effect.9 13 Thus, it can be concluded that the observed changes are elicited by alterations in afterload. Changes in heart rate and blood pressure seem to be minimal after treatment of asthma patients with nebulised terbutaline.14 15 After oral, subcutaneous, intramuscular or intravenous treatment, however, heart rate and pulse pressure are increased as expected using a drug with a potent arteriolodilator effect. [16] [17] [18] In patients with heart failure the effect on both heart rate and blood pressure is blunted. In this study an increase in heart rate of 36% (p<O0O1) was found and pulse pressure increased by 84% (p<0-01), while mean blood pressure remained relatively constant. The response to terbutaline after pretreatment with atenolol was greater than expected, suggesting that the reflex tachycardia is not so much the result of an increase in sympathetic activity as of a decrease in parasympathetic tone. This is compatible with the investigations of Man In 'TVeld et al. 19 who blocked the reflex tachycardia after diazoxide administration with atropine pretreatment. The degree of beta blockade obtained by the standard dosage of 100 mg was not controlled by isoprenaline or exercise in the present study.
By echocardiography left ventricular end-diastolic dimension was found to be remarkably constant (Table 3 ). This might be because normal subjects took part in the experiment. In this case the filling pressure is initially low and will not decrease much despite a better emptying during systole, and so left ventricular end-diastolic dimension will remain constant in contrast to investigations on patients with heart disease where an improved emptying will reduce left ventricular end-diastolic pressure and thereby left ventricular end-diastolic dimension. This is compat- The systolic time intervals with the closest correlation to invasive measurements of left ventricular function are pre-ejection period index and PEP/LVET.6 7 Furthermore, pre-ejection period index has a clear physiological background, representing the electromechanical delay plus the time necessary for the left ventricle to build up a pressure equal to the aortic pressure and will thus have a close inverse relation to dP/dt.2' Therefore, pre-ejection period index and PEP/LVET were the variables used in this study, and they decreased in accordance with results obtained by treatment of hypertension8 or from the opposite effect caused by increased afterload.22 23 This study showed the feasibility of correlating changes in cardiac function as measured by preejection period index and PEP/LVET with changes in left ventricular end-systolic dimension and systolic wall stress as indicators of afterload reduction after terbutaline administration. In a group of persons similar to those in this study, Fig. 2 may be used to estimate whether the haemodynamic effect of a drug can be explained by changes in afterload or contractility or both. For example, if a drug induces a decrease in left ventricular end-systolic dimension of 10% this may cause a decrease in pre-ejection period index of 4 to 13%. Thus, only if a decrease in pre-ejection period index greater than 13% is encountered in this example is an additional mechanism such as increased myocardial contractility necessary to explain the results. This figure will not necessarily be valid for a group of patients with heart disease who have abnormal left ventricular compliance and size. No difference was found by using percentage systolic wall stress instead of percentage left ventricular endsystolic dimension, so in Fig. 2a and 2b we have used the latter as it is simpler.
The present study has shown a statistically significant correlation between a decrease in left ventricular end-systolic dimension or systolic wall stress and changes in pre-ejection period index or PEP/ LVET in normal subjects. This, together with a former study,2 may improve our ability to evaluate the haemodynamic effect of drugs non-invasively.
